ADMINISTRATIVE CORE ABSTRACT The UAB Comprehensive Cancer Center's (UAB CCC) Senior Leadership and Administrative Unit work collaboratively under the leadership of the Director to develop, initiate, and implement the Center's strategic initiatives focused on achieving the Center's research mission. The CCC Administrative Unit serves as the central coordinating hub of the Center's activities with the primary goal of meeting the needs of Center members within the strategic framework developed by the Center's leadership. The Administrative Unit serves the CCC and its members through: 1) acquiring, maintaining and reporting data for informed strategic planning and decision support; 2) coordination and implementation of programmatic initiatives; 3) oversight and management of Center assets and resources including financial, space and facility; 4) facilitating faculty recruitment, 5) administering pilot grant and research development program; 6) representing the Center' interests with institutional administrative entities; 7) internal and external communications; and 9) grants management. The CCC Senior Leadership supports the mission of the Center through strategic planning and evaluation, oversight of CCC research activities, integration of the CCC's research themes across programmatic areas, and establishing collaborative relationships within the CCC, UAB and HudsonAlpha as well as with external institutions. Specifically, the CCC Senior Leaders provide oversight and guidance to the research programs, shared facilities, membership, strategic themes, resource management, and undergraduate, graduate and post-graduate cancer research training programs. The CCC Senior Leadership is comprised of eight eminent oncology scientists supported by the CCSG: Director ? Edward E. Partridge, MD Deputy Director ? Ravi Bhatia, MD, PhD HudsonAlpha President and CEO- Richard Myers, PhD Associate Director for Basic Research ? Etty (Tika) Benveniste, PhD Associate Director for Translational Research ? Mary-Ann Bjornsti, PhD Associate Director for Clinical Research ? Harry Erba, MD, PhD Associate Director for Prevention and Control ? Wendy Demark-Wahnefried, PhD Associate Director for Drug Discovery and Development ? Richard Whitley, MD Associate Director for Administration ? Michael J. Bertram, PhD, MBA

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-45
Application #
9254449
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
45
Fiscal Year
2017
Total Cost
$566,136
Indirect Cost
$180,270
Name
University of Alabama Birmingham
Department
Type
Domestic Higher Education
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Kasten, Benjamin B; Oliver, Patsy G; Kim, Harrison et al. (2018) 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models. Int J Mol Sci 19:
Subramaniam, Akila; Blanchard, Christina T; Erickson, Britt K et al. (2018) Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol 132:20-27
Garner, Evan F; Williams, Adele P; Stafman, Laura L et al. (2018) FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts. Sci Rep 8:6913
Stoll, Matthew L; Weiss, Pamela F; Weiss, Jennifer E et al. (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:14
Locke, Landon W; Kothandaraman, Shankaran; Tweedle, Michael et al. (2018) Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. Tuberculosis (Edinb) 108:201-210
Fancy, Romone M; Kim, Harrison; Napier, Tiara et al. (2018) Calmodulin antagonist enhances DR5-mediated apoptotic signaling in TRA-8 resistant triple negative breast cancer cells. J Cell Biochem 119:6216-6230
Barrington, David A; Champion, Macie L; Boitano, Teresa K L et al. (2018) Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic. Gynecol Oncol 149:337-340
Banerjee, N Sanjib; Wang, Hsu-Kun; Beadle, James R et al. (2018) Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures. Antiviral Res 150:164-173
Keene, Kimberly S; King, Tari; Hwang, E Shelley et al. (2018) Molecular determinants of post-mastectomy breast cancer recurrence. NPJ Breast Cancer 4:34
Kleinpeter, Alex B; Jureka, Alexander S; Falahat, Sally M et al. (2018) Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds. J Biol Chem 293:14659-14668

Showing the most recent 10 out of 747 publications